Pharmaceutical formulation

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S465000, C424S468000, C424S484000, C424S488000, C514S777000, C514S781000, C514S960000, C514S369000, C514S355000, C514S563000

Reexamination Certificate

active

07338667

ABSTRACT:
The present invention concerns an extended release formulation having an accelerating erosion and/or dissolution rate of the surface of the formulation. The formulation comprises a drug having low solubility in water dispersed or dissolved in at least one erasable hydrophilic polymeric matrix.

REFERENCES:
patent: 4803081 (1989-02-01), Falk et al.
patent: 5451409 (1995-09-01), Rencher et al.
patent: 5593695 (1997-01-01), Merrill et al.
patent: 6132772 (2000-10-01), Sherman
patent: 6555139 (2003-04-01), Sharma
patent: 0 776 660 (1997-06-01), None
patent: 0 852 141 (1998-07-01), None
patent: WO 99/01121 (1999-01-01), None
International-Type Search Report dated Sep. 28, 2001 issued in the parent application's (U.S. Appl. No. 09/788,414) Swedish counterpart (i.e., No. 0004671-4).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2815799

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.